Antibody Therapeutics for Life

Notices

PharmAbcine,6th BioCentury-BioHelix CHINA HEALTHCARE SUMMIT 2019
  • Written by PharmAbcine
  • Written date 2019-10-17 09:15:02
  • Inquire 692
Attachments BioCentury BayHelix China Summit Draft Agenda_PharmAbcine Inc..pdf

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Hyunsun Park, COO/CBO is invited by BioCentury to present at the 6th BioCentury-BioHelix CHINA HEALTHCARE SUMMIT 2019 (https://www.biocentury.com/conferences/china-healthcare-summit-2019?utm_source=marketo&utm_medium=email&utm_campaign=BCHS_Bootcamp&mkt_tok=eyJpIjoiTnpjek1XVmhaVGd6TWpBdyIsInQiOiJJakEyeWowMUJoTFwvOEVuYkFSVkIrbkVQNzhPUTZBa0J3Qk5mYzIwZ0tlTm8xWXh1cVhNYVFvNTZIRG9Ga0FlRzM1azNyUDBtNGtUN0VhNHVLOXYrUmR6Q3liUE9wZVwvYTZqYVBSaFcrRkNvVVVDK0Z5T25GZE5tSUFoRVBnc0V3In0%3D) in Shanghai, on November 18-20.

Dr. Hyunsun Park, COO/CBO and Dr. Sung Woo Kim, CFO will also attend to cover multiple partnering meetings during the CHINA HEALTHCARE SUMMIT 2019. 



Please check the attached file for details.

List





Prev PharmAbcine,BioEurope 2019
Next PharmAbcine, Korea-Europe Gathering for Open Innovation_KDHI